Regenxbio (RGNX) Other Non-Current Liabilities (2015 - 2026)
Regenxbio's Other Liabilities was $486,000 in Q2 2026, down 26.8% from $664,000 a year earlier and down 21.9% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, Other Liabilities at Regenxbio came in at $638,000, down 82.4% from FY2024.
- Other Liabilities has now declined for five consecutive years, with a five-year compound annual growth rate of -67.5% (FY2020 to FY2025).
- In earlier years, Other Liabilities was $3.64 million in FY2024 (-92.7%), $49.73 million in FY2023 (-49.2%), $97.84 million in FY2022 (-27.1%) and $134.21 million in FY2021 (-23.3%).
- The Q2 2026 figure marks the lowest quarterly Other Liabilities since Q4 2015.
- Compared with a year earlier, Other Liabilities has declined for 19 straight quarters, with an average decline of 75.5% over the last eight quarters.
- Across the past five years, year-over-year decline in Other Liabilities ran from 19.1% in Q2 2022 to 98.5% in Q2 2025.
- Per Business Quant data, RGNX's Other Liabilities in the three quarters before Q2 2026 was $622,000 (Q1 2026), $638,000 (Q4 2025) and $648,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Regenxbio | 418.33 Mn | -341.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 486,000.00 |
| Dec 31, 2025 | 638,000.00 |
| Sep 30, 2025 | 648,000.00 |
| Jun 30, 2025 | 664,000.00 |
| Mar 31, 2025 | 11.80 Mn |
| Dec 31, 2024 | 3.64 Mn |
| Sep 30, 2024 | 38.63 Mn |
| Jun 30, 2024 | 44.61 Mn |
| Mar 31, 2024 | 48.19 Mn |
| Dec 31, 2023 | 49.73 Mn |
| Sep 30, 2023 | 59.28 Mn |
| Jun 30, 2023 | 73.46 Mn |
| Mar 31, 2023 | 83.37 Mn |
| Dec 31, 2022 | 97.84 Mn |
| Sep 30, 2022 | 111.75 Mn |
| Jun 30, 2022 | 122.70 Mn |
| Mar 31, 2022 | 130.19 Mn |
| Dec 31, 2021 | 134.21 Mn |
| Sep 30, 2021 | 144.80 Mn |
| Jun 30, 2021 | 151.59 Mn |
API Access
Regenxbio Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();